A 1:1 propensity matching was also employed to account for confounders, including demographics, comorbidities, insulin use, and use of other second-line diabetic agents
e-mail: [email protected] This article was submitted to Frontiers in Cellular Endocrinology, a specialty of Frontiers in Endocrinology
They reported improved developmental potential up to the blastocyst stage with higher blastocyst formation rate and increased total cell count and activity when the oocytes were matured in culture media added with 0.10.5 mg/mL LC
Introduction Glucagon like peptide-1 (GLP-1) is a 30 or 31 amino acid long peptide hormone mainly secreted by 3 tissues in the human body: enteroendocrine L cells in the distal intestine, alpha cells in the pancreas, and the central nervous system ( Brief Introduction and Physiological Function of Glucagon Like Peptide-1 Receptor Agonists Glucagon like peptide-1 (GLP-1) is the second incretin identified in 1983
Patients taking medications that can cause hypoglycaemia (such as when GLP-1 therapy is combined with insulin or sulfonylureas) should follow DVLA 'Assessing fitness to drive' guidance, including appropriate glucose monitoring before and during driving
Yang B, Lin X, Yu N, Gao H, Zhang Y, Liu W
